No shortage on file

DUPIXENT

SANOFI-AVENTIS CANADA INC

Quick answers

Is there a shortage of DUPIXENT in Canada?

No. There is no current shortage of DUPIXENT 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DUPIXENT

SANOFI-AVENTIS CANADA INC

200MG · DIN 02524252

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02510049

Strength

300MG

Dosage Form

Solution

Route

Subcutaneous

Active Ingredient

DUPILUMAB

See all DUPILUMAB products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from SANOFI-AVENTIS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

20MCG · DIN 02464284

10MCG · DIN 02464276

DIN 02464349

100UNIT · DIN 02469901

ADMELOG

100UNIT · DIN 02469898

ADMELOG SOLOSTAR

100UNIT · DIN 02469871